Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancer

G L Ceresoli , M Bonomi , F De Vincenzo , P A Zucali
Quarterly Journal of Nuclear Medicine and Molecular Imaging 59 ( 4) 374 -380

4
2015
Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results.

F Calabrò , L Cerbone , G Baciarello , G L Ceresoli
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 59 ( 4) 400 -410

2
2015
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

G L Ceresoli , B Castagneto , P A Zucali , A Favaretto
British Journal of Cancer 99 ( 1) 51 -56

126
2008
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

F Cappuzzo , S Bartolini , G L Ceresoli , S Tamberi
British Journal of Cancer 90 ( 1) 82 -86

55
2004
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.

F Cappuzzo , L Toschi , I Domenichini , S Bartolini
British Journal of Cancer 93 ( 12) 1334 -1340

77
2005
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma.

G L Ceresoli , P A Zucali , M Mencoboni , M Botta
British Journal of Cancer 109 ( 3) 552 -558

99
2013
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

G L Ceresoli , F Grosso , P A Zucali , M Mencoboni
British Journal of Cancer 111 ( 2) 220 -226

24
2014
A reply to "managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy".

Giovanni L. Ceresoli , Davide Franceschini , Paolo Ghirardelli , Marta Scorsetti
Lung Cancer

2021
Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose

Giovanni L. Ceresoli , Arturo Chiti , Paolo A. Zucali , Marcello Rodari
Journal of Clinical Oncology 24 ( 28) 4587 -4593

130
2006
Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma

Giovanni L. Ceresoli , Paolo A. Zucali , Adolfo G. Favaretto , Francesco Grossi
Journal of Clinical Oncology 24 ( 9) 1443 -1448

211
2006
Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Vanesa Gregorc , Paolo A. Zucali , Armando Santoro , Giovanni L. Ceresoli
Journal of Clinical Oncology 28 ( 15) 2604 -2611

97
2010
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Paolo A. Zucali , Giovanni L. Ceresoli , Isabella Garassino , Fabio De Vincenzo
Cancer 112 ( 7) 1555 -1561

126
2008
Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy.

Fausto Meriggi , Claudio Codignola , Giordano D. Beretta , Giovanni L. Ceresoli
Tumori 103 ( 5) 443 -448

13
2017
A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme.

Michele Reni , Cesare Cozzarini , Andrés J. M. Ferreri , Giovanni L. Ceresoli
Cancer Investigation 18 ( 6) 510 -515

10
2000
Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases.

Giovanni L. Ceresoli , Andrés J.M. Ferreri , Stefano Cordio , Eugenio Villa
Oncology 55 ( 6) 525 -532

15
1998
Consolidation Radiotherapy to Bulky or Semibulky Lesions in the Management of Stage III–IV Diffuse Large B Cell Lymphomas

Andrés J.M. Ferreri , Stefania Dell’Oro , Michele Reni , Giovanni L. Ceresoli
Oncology 58 ( 3) 219 -226

41
2000
Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

Federico Cappuzzo , Marileila Varella-Garcia , Hisayuki Shigematsu , Irene Domenichini
Journal of Clinical Oncology 23 ( 22) 5007 -5018

362
2005
Assessment of tumor response in malignant pleural mesothelioma.

Giovanni L. Ceresoli , Arturo Chiti , Paolo A. Zucali , Federico Cappuzzo
Cancer Treatment Reviews 33 ( 6) 533 -541

45
2007
11C-labeled methionine and evaluation of malignant pleural mesothelioma.

Giovanni L. Ceresoli , Arturo Chiti , Armando Santoro
The New England Journal of Medicine 357 ( 19) 1982 -1984

7
2007
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

Jaine K. Blayney , Giovanni L. Ceresoli , Bruno Castagneto , Mary E.R. O’Brien
European Journal of Cancer 48 ( 16) 2983 -2992

23
2012